Motley Idiot contributor Jamie Louko retains shopping for Veeva Methods (VEEV 1.43%) inventory. Veeva has a powerful moat, as pharmaceutical and biotech corporations depend on its merchandise closely and barely go away.
Try the video for his full ideas!
*Inventory costs used had been the noon costs of Jan. 22, 2023. The video was printed on Jan. 23, 2023.
Jamie Louko has positions in Veeva Methods. Zane Fracek has no place in any of the shares talked about. The Motley Idiot has positions in and recommends Veeva Methods. The Motley Idiot has a disclosure coverage. Zane Fracek and Jamie Louko are associates of The Motley Idiot and could also be compensated for selling its companies. In the event you select to subscribe via their hyperlink, they are going to earn some more money that helps their channel. Their opinions stay their very own and are unaffected by The Motley Idiot.
